Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - eric ostertag
Human monoclonal autoantibodies to ADAMTS13 and uses thereof
Human anti-ADAMTS13 antibodies cloned from patients with acquired thrombotic thromobocytopenia purpura (TTP) for use in targeted therapies, and generation of animal models that recapitulate pathologic features of TPP. Technology Overview: Thrombotic thrombocytopenic purpura (TTP) is a rare but life-threatening blood disorder where blood clots...
X. Long Zheng
Therapeutics & Vaccines
Research Tools & Reagents
© 2020. All Rights Reserved. Powered by